The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
Open accessAbstract
Diffuse intrinsic pontine glioma (DIPG) remains a fatal brainstem tumor demanding innovative therapies. As B7-H3 (CD276) is expressed on central nervous system (CNS) tumors, we designed B7-H3–specific chimeric antigen receptor (CAR) T cells, confirmed their preclinical efficacy, and opened BrainChild-03 (NCT04185038), a first-in-human phase I trial administering repeated locoregional B7-H3 CAR T cells to children with recurrent/refractory CNS tumors and DIPG. Here, we report the results of the first three evaluable patients with DIPG (including two who enrolled after progression), who received 40 infusions with no dose-limiting toxicities. One patient had sustained clinical and radiographic improvement through 12 months on study. Patients exhibited correlative evidence of local immune activation and persistent cerebrospinal fluid (CSF) B7-H3 CAR T cells. Targeted mass spectrometry of CSF biospecimens revealed modulation of B7-H3 and critical immune analytes (CD14, CD163, CSF-1, CXCL13, and VCAM-1). Our data suggest the feasibility of repeated intracranial B7-H3 CAR T-cell dosing and that intracranial delivery may induce local immune activation. Significance: This is the first report of repeatedly dosed intracranial B7-H3 CAR T cells for patients with DIPG and includes preliminary tolerability, the detection of CAR T cells in the CSF, CSF cytokine elevations supporting locoregional immune activation, and the feasibility of serial mass spectrometry from both serum and CSF. This article is highlighted in the In This Issue feature, p. 1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Brown, C. E., Alizadeh, D., Starr, R., Weng, L., Wagner, J. R., Naranjo, A., Ostberg, J. R., Blanchard, M. S., Kilpatrick, J., Simpson, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610497 · Cited by 1,836
Self-citationGardner, R. A., Finney, O., Annesley, C., Brakke, H., Summers, C., Leger, K., Bleakley, M., Brown, C., Mgebroff, S., Kelly-Spratt, K. S., et al. (2017) · Blood · doi:10.1182/blood-2017-02-769208 · Cited by 1,121
Self-citationMrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I., Heppner, F. L., Kipnis, J., Merkler, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.011 · Cited by 1,010
Orchestrating single-cell analysis with Bioconductor
Amezquita, R. A., Lun, A. T. L., Becht, E., Carey, V. J., Carpp, L. N., Geistlinger, L., Marini, F., Rue-Albrecht, K., Risso, D., Soneson, C., et al. (2020) · Nature Methods · doi:10.1038/s41592-019-0654-x · Cited by 945
Gruver, A., Hudson, L., & Sempowski, G. (2007) · The Journal of Pathology · doi:10.1002/path.2104 · Cited by 834 · cited 1×
“Immune effector cell characteristics and function are known to vary by age (49, 50) and the median age of the initial 3 enrolled patients is above the historical median age for children with DIPG.”
BackgroundGD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Majzner, R. G., Ramakrishna, S., Yeom, K. W., Patel, S., Chinnasamy, H., Schultz, L. M., Richards, R. M., Jiang, L., Barsan, V., Mancusi, R., et al. (2022) · Nature · doi:10.1038/s41586-022-04489-4 · Cited by 823
The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics
Pino, L. K., Searle, B. C., Bollinger, J. G., Nunn, B., MacLean, B., & MacCoss, M. J. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21540 · Cited by 800
Majzner, R. G., Theruvath, J. L., Nellan, A., Heitzeneder, S., Cui, Y., Mount, C. W., Rietberg, S. P., Linde, M. H., Xu, P., Rota, C., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0432 · Cited by 681
Self-citationWang, X., Chang, W.-C., Wong, C. W., Colcher, D., Sherman, M., Ostberg, J. R., Forman, S. J., Riddell, S. R., & Jensen, M. C. (2011) · Blood · doi:10.1182/blood-2011-02-337360 · Cited by 600
Self-citationEnhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Guedan, S., Posey, A. D., Shaw, C., Wing, A., Da, T., Patel, P. R., McGettigan, S. E., Casado-Medrano, V., Kawalekar, O. U., Uribe-Herranz, M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96976 · Cited by 580
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
Krishna, S., Lowery, F. J., Copeland, A. R., Bahadiroglu, E., Mukherjee, R., Jia, L., Anibal, J. T., Sachs, A., Adebola, S. O., Gurusamy, D., et al. (2020) · Science · doi:10.1126/science.abb9847 · Cited by 547
Hudecek, M., Lupo-Stanghellini, M.-T., Kosasih, P. L., Sommermeyer, D., Jensen, M. C., Rader, C., & Riddell, S. R. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0330 · Cited by 544
Self-citationDu, H., Hirabayashi, K., Ahn, S., Kren, N. P., Montgomery, S. A., Wang, X., Tiruthani, K., Mirlekar, B., Michaud, D., Greene, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.002 · Cited by 479
Engineering and Design of Chimeric Antigen Receptors
Guedan, S., Calderon, H., Posey, A. D., & Maus, M. V. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.009 · Cited by 453
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
Jin, L., Tao, H., Karachi, A., Long, Y., Hou, A. Y., Na, M., Dyson, K. A., Grippin, A. J., Deleyrolle, L. P., Zhang, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11869-4 · Cited by 385
A targeted proteomics–based pipeline for verification of biomarkers in plasma
Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1900 · Cited by 364
Self-citationVitanza, N. A., Johnson, A. J., Wilson, A. L., Brown, C., Yokoyama, J. K., Künkele, A., Chang, C. A., Rawlings-Rhea, S., Huang, W., Seidel, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01404-8 · Cited by 321
Self-citationIsotope dilution strategies for absolute quantitative proteomics
Brun, V., Masselon, C., Garin, J., & Dupuis, A. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.03.007 · Cited by 316
Theruvath, J., Sotillo, E., Mount, C. W., Graef, C. M., Delaidelli, A., Heitzeneder, S., Labanieh, L., Dhingra, S., Leruste, A., Majzner, R. G., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0821-8 · Cited by 302
Jain, M. D., Zhao, H., Wang, X., Atkins, R., Menges, M., Reid, K., Spitler, K., Faramand, R., Bachmeier, C., Dean, E. A., et al. (2021) · Blood · doi:10.1182/blood.2020007445 · Cited by 297
Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Loo, D., Alderson, R. F., Chen, F. Z., Huang, L., Zhang, W., Gorlatov, S., Burke, S., Ciccarone, V., Li, H., Yang, Y., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0715 · Cited by 284
Van Oekelen, O., Aleman, A., Upadhyaya, B., Schnakenberg, S., Madduri, D., Gavane, S., Teruya-Feldstein, J., Crary, J. F., Fowkes, M. E., Stacy, C. B., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01564-7 · Cited by 279
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
Pérez‐Larraya, J. G., García-Moure, M., Labiano, S., Patiño‐García, A., Dobbs, J., González-Huarriz, M., Zalacaín, M., Marrodán, L., Martínez-Vélez, N., Puigdelloses, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2202028 · Cited by 279
Whiteaker, J. R., Zhao, L., Zhang, H. Y., Feng, L.-C., Piening, B. D., Anderson, L., & Paulovich, A. G. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2006.12.023 · Cited by 270
Self-citationDonovan, L. K., Delaidelli, A., Joseph, S. K., Bielamowicz, K., Fousek, K., Holgado, B. L., Manno, A., Srikanthan, D., Gad, A. Z., Van Ommeren, R., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0827-2 · Cited by 246
CPTAC Assay Portal: a repository of targeted proteomic assays
the Clinical Proteomic Tumor Analysis Consortium (CPTAC), Whiteaker, J. R., Halusa, G. N., Hoofnagle, A. N., Sharma, V., MacLean, B., Yan, P., Wrobel, J. A., Kennedy, J., Mani, D. R., et al. (2014) · Nature Methods · doi:10.1038/nmeth.3002 · Cited by 223
Self-citationAbbatiello, S. E., Schilling, B., Mani, D. R., Zimmerman, L. J., Hall, S. C., MacLean, B., Albertolle, M., Allen, S., Burgess, M., Cusack, M. P., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.047050 · Cited by 215
Self-citationFine-tuning the CAR spacer improves T-cell potency
Watanabe, N., Bajgain, P., Sukumaran, S., Ansari, S., Heslop, H. E., Rooney, C. M., Brenner, M. K., Leen, A. M., & Vera, J. F. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1253656 · Cited by 203
Lieberman, N. A. P., DeGolier, K., Kovar, H. M., Davis, A., Hoglund, V., Stevens, J., Winter, C., Deutsch, G., Furlan, S. N., Vitanza, N. A., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noy145 · Cited by 197
Self-citationB7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
Tang, X., Zhao, S., Zhang, Y., Wang, Y., Zhang, Z., Yang, M., Zhu, Y., Zhang, G., Guo, G., Tong, A., et al. (2019) · Molecular Therapy - Oncolytics · doi:10.1016/j.omto.2019.07.002 · Cited by 197
Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Abraham, D., Hoofnagle, A. N., & Meikle, A. W. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.195594 · Cited by 193
Kuhn, E., Whiteaker, J. R., Mani, D. R., Jackson, A. M., Zhao, L., Pope, M. E., Smith, D., Rivera, K. D., Anderson, N. L., Skates, S. J., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013854 · Cited by 183
Self-citationB7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
Nehama, D., Di Ianni, N., Musio, S., Du, H., Patané, M., Pollo, B., Finocchiaro, G., Park, J. J. H., Dunn, D. E., Edwards, D. S., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.030 · Cited by 183
Self-citationKünkele, A., Johnson, A. J., Rolczynski, L. S., Chang, C. A., Hoglund, V., Kelly-Spratt, K. S., & Jensen, M. C. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0200 · Cited by 182
Self-citationB7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhou, Z., Luther, N., Ibrahim, G. M., Hawkins, C. E., Vibhakar, R., Handler, M. H., & Souweidane, M. M. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1021-2 · Cited by 160
Netzel, B. C., Grebe, S. K. G., Leon, B. G. C., Castro, M. R., CLARK, P. M. S., Hoofnagle, A. N., Spencer, C. A., Turcu, A. F., & Algeciras‐Schimnich, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1967 · Cited by 157
Haydar, D., Houke, H., Chiang, J., Yi, Z., Odé, Z., Caldwell, K. J., Zhu, X., Mercer, K., Stripay, J. L., Shaw, T. I., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa278 · Cited by 144
Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials
Vitanza, N. A., & Monje, M. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0577-y · Cited by 136
Self-citationB7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
Zhang, Z., Jiang, C., Liu, Z., Yang, M., Tang, X., Wang, Y., Zheng, M., Huang, J., Zhong, K., Zhao, S., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.019 · Cited by 134
Neubert, H., Shuford, C. M., Olah, T. V., Garofolo, F., Schultz, G. A., Jones, B. R., Amaravadi, L., Laterza, O. F., Xu, K., & Ackermann, B. L. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz022 · Cited by 109
Dorshkind, K. A., & Swain, S. L. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.001 · Cited by 94
Vitanza, N. A., Biery, M. C., Myers, C. H., Ferguson, E., Zheng, Y., Girard, E. J., Przystal, J. M., Park, G., Noll, A., Pakiam, F. J., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa249 · Cited by 79
Self-citationTang, X., Liu, F., Liu, Z., Cao, Y. L., Zhang, Z., Wang, Y., Huang, J., Fan, S., Zhao, S., Chen, Y., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1137 · Cited by 71
Whiteaker, J. R., Zhao, L., Lin, C., Yan, P., Wang, P., & Paulovich, A. G. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015347 · Cited by 69
Self-citationHembrough, T., Thyparambil, S. P., Liao, W.-L., Darfler, M. M., Abdo, J., Bengali, K. M., Hewitt, S. M., Bender, R. A., Krizman, D. B., & Burrows, J. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.002 · Cited by 64
Kennedy, J. J., Whiteaker, J. R., Kennedy, L. C., Bosch, D. E., Lerch, M. L., Schoenherr, R. M., Zhao, L., Lin, C., Chowdhury, S., Kilgore, M., et al. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab047 · Cited by 53
Self-citationKennedy, J. J., Whiteaker, J. R., Schoenherr, R. M., Yan, P., Allison, K. H., Shipley, M., Lerch, M. L., Hoofnagle, A. N., Baird, G. S., & Paulovich, A. G. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00245 · Cited by 51
Self-citationTalbot, L. J., Chabot, A., Funk, A., Nguyen, P., Wagner, J., Ross, A. B., Tillman, H. S., Davidoff, A. M., Gottschalk, S. M., & DeRenzo, C. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691741 · Cited by 44
Quantification of Proteins Using Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry
Zhao, L., Whiteaker, J. R., Pope, M. E., Kuhn, E. W., Jackson, A., Anderson, N. L., Pearson, T. W., Carr, S. A., & Paulovich, A. G. (2011) · Journal of Visualized Experiments · doi:10.3791/2812 · Cited by 37
Self-citationErskine, C. L., Henle, A. M., & Knutson, K. L. (2012) · Journal of Visualized Experiments · doi:10.3791/3683 · Cited by 37
Rapid Multiplexed Proteomic Screening for Primary Immunodeficiency Disorders From Dried Blood Spots
Collins, C. J., Chang, I. J., Jung, S., Dayuha, R., Whiteaker, J. R., Segundo, G. R. S., Torgerson, T. R., Ochs, H. D., Paulovich, A. G., & Hahn, S. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02756 · Cited by 37
Self-citationDo, M., Kim, H., Yeo, I., Lee, J., Park, I. A., Ryu, H. S., & Kim, Y. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa178 · Cited by 36
Collins, C. J., Yi, F., Dayuha, R., Whiteaker, J. R., Ochs, H. D., Freeman, A. F., Su, H. C., Paulovich, A. G., Segundo, G. R. S., Torgerson, T. R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00464 · Cited by 35
Self-citationWhiteaker, J. R., Zhao, L., Saul, R., Kaczmarczyk, J. A., Schoenherr, R. M., Moore, H. D., Jones-Weinert, C. W., Ivey, R. G., Lin, C., Hiltke, T., et al. (2018) · Radiation Research · doi:10.1667/rr14963.1 · Cited by 32
Self-citationCeppi, F., Wilson, A. L., Annesley, C., Kimmerly, G. R., Summers, C. N., Brand, A., Seidel, K. D., Wu, Q. V., Beebe, A., Brown, C., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0501 · Cited by 29
Self-citationWhiteaker, J. R., Lundeen, R. A., Zhao, L., Schoenherr, R. M., Burian, A., Huang, D., Voytovich, U. J., Wang, T., Kennedy, J. J., Ivey, R. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765898 · Cited by 27
Self-citationErskine, C. L., Henle, A. M., & Knutson, K. L. (2012) · Journal of Visualized Experiments · doi:10.3791/3683-v · Cited by 20
Whiteaker, J. R., Zhao, L., Ivey, R. G., Sánchez-Bonilla, M., Moore, H. D., Schoenherr, R. M., Yan, P., Lin, C., Shimamura, A., & Paulovich, A. G. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.03.003 · Cited by 17
Self-citationQuantification of Proteins Using Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry
Lei, Z., Whiteaker, J. R., Pope, M. E., Kuhn, E. W., Jackson, A., Anderson, N. L., Pearson, T. W., Carr, S. A., & Paulovich, A. G. (2011) · Journal of Visualized Experiments · doi:10.3791/2812-v · Cited by 16
Self-citationBiery, M. C., Noll, A., Myers, C. H., Morris, S. M., Winter, C., Pakiam, F. J., Cole, B., Browd, S. R., Olson, J. M., & Vitanza, N. A. (2020) · Journal of Experimental Neurology · doi:10.33696//neurol.1.025 · Cited by 10
Self-citation(2020) · Journal of Experimental Neurology · doi:10.33696/neurol.1.025 · Cited by 6
Cited by
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
Choi, B. D., Gerstner, E. R., Frigault, M. J., Leick, M. B., Mount, C. W., Balaj, L., Nikiforow, S., Carter, B. S., Curry, W. T., Gallagher, K., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2314390 · Cited by 453
Bagley, S. J., Logun, M., Fraietta, J. A., Wang, X., Desai, A. S., Bagley, L. J., Nabavizadeh, A., Jarocha, D., Martins, R., Maloney, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02893-z · Cited by 381
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Peng, L., Sferruzza, G., Yang, L., Zhou, L., & Chen, S. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01207-0 · Cited by 373
Brown, C. E., Hibbard, J. C., Alizadeh, D., Blanchard, M. S., Natri, H. M., Wang, D., Ostberg, J. R., Aguilar, B., Wagner, J. R., Paul, J. A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02875-1 · Cited by 345
Self-citation
Metadata
- Authors
- Vitanza, N. A., Wilson, A. L., Huang, W., Seidel, K., Brown, C., Gustafson, J. A., Yokoyama, J. K., Johnson, A. J., Baxter, B. A., Koning, R. W., Reid, A. N., Meechan, M., Biery, M. C., Myers, C., Rawlings-Rhea, S. D., Albert, C. M., Browd, S. R., Hauptman, J. S., Lee, A., Ojemann, J. G., Berens, M. E., Dun, M. D., Foster, J. B., Crotty, E. E., Leary, S. E. S., Cole, B. L., Perez, F. A., Wright, J. N., Orentas, R. J., Chour, T., Newell, E. W., Whiteaker, J. R., Zhao, L., Paulovich, A. G., Pinto, N., Gust, J., Gardner, R. A., Jensen, M. C., & Park, J. R.
- Venue
- Cancer Discovery
- Published
- 2022-10-19
- Volume
- 13
- Issue
- 1
- Pages
- 114-131
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W4306795470
- Cited by
- 279
- References
- 64
- FWCI
- 19.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.